Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
Cue Biopharma announced it will receive a $7.5 million preclinical milestone payment from Boehringer Ingelheim following the selection and approval of its first compound for lead optimization. This milestone validates the progress of Cue Biopharma's collaboration to develop innovative therapeutics for autoimmune and inflammatory diseases leveraging…
Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) announced that it will release its first quarter 2026 financial results after market close on April 28, 2026, followed by a conference call on April 29 to discuss performance and recent events. The company is a real estate investment trust specializing in commercial real estate debt investment…
Artiva Biotherapeutics, a clinical-stage biotech firm focused on cell therapies for autoimmune diseases and cancers, will participate in panel discussions and a fireside chat at the upcoming Needham Virtual Healthcare Conference, showcasing its lead AlloNK® program and pipeline advancement.
Tyson Foods, Inc. announced it will release its second quarter 2026 financial results on May 4, 2026, followed by a management conference call and webcast. Supplemental materials will be available prior to the market opening. The call will provide investors and analysts insights into the company's performance for the quarter.
Constellation Brands reported its financial results for the full fiscal year and fourth quarter of 2026, with a scheduled conference call featuring current and incoming CEOs. The company highlighted its position as a leading international beverage alcohol producer and reiterated its commitment to sustainability and growth across its brands.
3 E Network Technology Group Limited announced that it has regained compliance with Nasdaq's minimum bid price requirement, avoiding delisting. Following a period below the $1 per share threshold, the company's stock price rose above $1 for ten consecutive days, leading to the cancellation of a previously planned appeal. The company sees this compl…
Applied Digital Corporation reported fiscal Q3 2026 revenues of $126.6 million, a 139% increase year-over-year, driven by its HPC Hosting and Data Center Hosting businesses. The company broke ground on a major new 300 MW AI Factory campus, secured $2.15 billion in senior secured notes to fund data center development, and strengthened lease agreemen…
Nasdaq announced its trading volumes for March 2026 along with quarterly volumes, estimated revenue capture, number of listings, and index statistics for the first quarter ended March 31, 2026. The detailed data is available on Nasdaq's Investor Relations website.
RxSight, a U.S.-listed ophthalmic medical device company, announced that over 300,000 Light Adjustable Lens implants have been performed, marking a significant milestone. The company is presenting extensive scientific research on its innovative lens technology at the ASCRS 2026 meeting and is launching a new marketing program highlighting surgeon e…
AXIL Brands, Inc. announced financial results for Q3 fiscal 2026, showing a 5.4% increase in net sales to $7.3 million driven by growing demand for their hearing protection and enhancement products. Despite higher costs due to tariffs and expanded marketing expenses, the company maintained profitability with net income of $0.2 million. Retail distr…
Our Bond, Inc., a NASDAQ-listed company specializing in AI-powered preventative personal security, announced expansion of its services into Brazil by one of the largest US multinational companies, marking its fourth country deployment. This expansion represents potential annual revenue of approximately $2 million and demonstrates Bond's ability to …
ImmuCell Corporation announced preliminary, unaudited sales results for Q1 2026 showing a 28.4% increase in total product sales to $10.4 million compared to Q1 2025. Domestic sales rose significantly by 35.7%, driven primarily by Tri-Shield® First Defense® sales which grew 38.5%. International sales declined by 30.2%. The company attributes strong …
Vishay Intertechnology, Inc. announced its 2026 Annual Meeting of Stockholders will occur virtually on May 18, 2026, allowing stockholders to participate online. Proxy materials are available electronically and in paper format. The company highlights its broad semiconductor and passive component portfolio serving multiple technology sectors worldwi…
Crinetics Pharmaceuticals will report its first quarter 2026 financial results on May 7, 2026, followed by a conference call to discuss these results and provide a business update. The company focuses on developing novel therapies for endocrine diseases and tumors, with a strong pipeline including FDA-approved PALSONIFY™ and several investigational…
Ascendis Pharma announced new Week 52 data from its Phase 2 COACH trial demonstrating that combination therapy with once-weekly TransCon CNP and TransCon hGH significantly improved clinical measures beyond linear growth in children with achondroplasia, including arm span, spinal canal dimensions, and leg alignment. These results suggest enhanced th…
Norwood Financial Corp announced it will release its first quarter 2026 financial results before the market opens on April 27, 2026, followed by a webcast and conference call to discuss the results. The company operates through its subsidiary Wayne Bank with 33 community offices in parts of Pennsylvania and New York and has total assets of $2.9 bil…
New Era Energy & Digital, Inc. has initiated an underwritten public offering of common stock on NASDAQ to raise proceeds primarily for repaying outstanding borrowings under a senior secured convertible promissory note and for general corporate purposes. The offering includes an option for underwriters to purchase additional shares and is subject to…
XMax Inc. announced the deployment of a cloud-based AI inference platform developed with Cloud Alliance Inc., marking a significant step in its transition toward a software-driven AI business. This platform aims to enable scalable AI application development, multi-model integration, and potential commercialization, supporting both internal operatio…
MacroGenics announced that the FDA has removed the partial clinical hold on its Phase 2 LINNET study investigating lorigerlimab, a bispecific antibody targeting PD-1 and CTLA-4, for gynecologic cancers. The company plans to resume enrollment under a revised protocol with enhanced safety measures and aims to provide a clinical update by mid-2026. To…
The Children's Place, a leading North American children’s specialty retailer with a strong omni-channel and digital presence, will release its fourth quarter and full fiscal year 2025 financial results along with the annual shareholder letter on April 10, 2026.
Pilgrim's Pride Corporation announced it will release its first quarter 2026 financial results after the U.S. market closes on April 29, 2026. The company will host an earnings call and webcast on April 30, 2026, to review the results with investors and analysts. The webcast will include prepared remarks and a Q&A session with management, with repl…
Ingersoll Rand Inc. will release its first quarter 2026 earnings after the market closes on April 28, 2026, followed by a live earnings conference call on April 29, 2026. The company provides industrial and life science solutions through a broad portfolio of brands and invites investors to participate in the webcast for a detailed financial update.
Cycurion, Inc., a provider of AI-driven cybersecurity solutions, announced a multi-year contract with a Fortune 500 company to support a major U.S. government agency. Valued at approximately $1 million in the first year, this partnership will deliver advanced AI cybersecurity services and application transition support over a minimum five-year term…
RenovoRx has obtained its first Notice of Allowance from the Japan Patent Office for a patent covering its RenovoCath device. This strengthens the company's global intellectual property around its unique targeted drug-delivery technology and supports expansion into the Japanese market. RenovoCath is an FDA-cleared catheter system designed to delive…
Scorpio Tankers Inc. announced a $325 million offering of 1.75% convertible senior notes due 2031, with an option to increase by $50 million. Concurrently, the company plans to repurchase approximately 1.34 million shares of common stock for about $100 million. Net proceeds will be used for the share repurchase and general corporate purposes, suppo…
